EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma drug trial halted: hope for severe cases unfulfilled
Disease control TerminatedThis study tested an oral drug called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce asthma attacks and improve lung function over 52 weeks. However, t…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:58 UTC
-
Asthma drug safety check: dexpramipexole under Long-Term review
Disease control TerminatedThis study looked at the long-term safety of dexpramipexole in adults with severe eosinophilic asthma. Participants were 509 people who had already completed an earlier phase III study. The main goal was to track side effects and changes in lab results, vital signs, and heart tes…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Asthma pill trial halted midway: what it means for patients
Disease control TerminatedThis study tested a daily pill called dexpramipexole for people with severe eosinophilic asthma that was not well controlled by standard inhalers. The goal was to see if the drug could reduce serious asthma attacks over one year. The trial was stopped early, so results are limite…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC